Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Fragment Screening Drug Discovery
The 2025-2030 World Outlook for Fragment Screening Drug Discovery This study covers the world outlook for fragment screening drug discovery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Sepsis Drugs
The 2025-2030 World Outlook for Sepsis Drugs This study covers the world outlook for sepsis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the ... Read More
-
The 2025-2030 World Outlook for Marine Derived Drugs
The 2025-2030 World Outlook for Marine Derived Drugs This study covers the world outlook for marine derived drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs
The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs This study covers the world outlook for alkylating gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Migraine Treatments
The 2025-2030 World Outlook for Migraine Treatments This study covers the world outlook for migraine treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Macrolide Drugs
The 2025-2030 World Outlook for Macrolide Drugs This study covers the world outlook for macrolide drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Huntington's Disease Therapeutics
The 2025-2030 World Outlook for Huntington's Disease Therapeutics This study covers the world outlook for Huntington's disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Drugs
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Drugs This study covers the world outlook for alpha-1 antitrypsin drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Drug Developments
The 2025-2030 World Outlook for Drug Developments This study covers the world outlook for drug developments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Drug Discovery Outsourcing
The 2025-2030 World Outlook for Drug Discovery Outsourcing This study covers the world outlook for drug discovery outsourcing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Biosimulation Technology Software
The 2025-2030 World Outlook for Biosimulation Technology Software This study covers the world outlook for biosimulation technology software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Peptide Synthesis
The 2025-2030 World Outlook for Peptide Synthesis This study covers the world outlook for peptide synthesis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Albumin Plasma Protein Therapeutics
The 2025-2030 World Outlook for Albumin Plasma Protein Therapeutics This study covers the world outlook for albumin plasma protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Metabolism Drugs
The 2025-2030 World Outlook for Metabolism Drugs This study covers the world outlook for metabolism drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Innovative Peptide Therapeutics
The 2025-2030 World Outlook for Innovative Peptide Therapeutics This study covers the world outlook for innovative peptide therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Orphan Drugs
The 2025-2030 World Outlook for Orphan Drugs This study covers the world outlook for orphan drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the ... Read More
-
The 2025-2030 World Outlook for Brain Tumor Diagnosis and Therapeutics
The 2025-2030 World Outlook for Brain Tumor Diagnosis and Therapeutics This study covers the world outlook for brain tumor diagnosis and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Tumor Necrosis Factor Inhibitor Drugs
The 2025-2030 World Outlook for Tumor Necrosis Factor Inhibitor Drugs This study covers the world outlook for tumor necrosis factor inhibitor drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Inhalation and Nasal Spray Drugs
The 2025-2030 World Outlook for Inhalation and Nasal Spray Drugs This study covers the world outlook for inhalation and nasal spray drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Microbiome Therapeutics
The 2025-2030 World Outlook for Microbiome Therapeutics This study covers the world outlook for microbiome therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Microbiome Therapeutics for Type 2 Diabetes
The 2025-2030 World Outlook for Microbiome Therapeutics for Type 2 Diabetes This study covers the world outlook for microbiome therapeutics for type 2 diabetes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for PEGylated Protein Therapeutics
The 2025-2030 World Outlook for PEGylated Protein Therapeutics This study covers the world outlook for PEGylated protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Cystic Fibrosis Therapeutics
The 2025-2030 World Outlook for Cystic Fibrosis Therapeutics This study covers the world outlook for cystic fibrosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for MRSA Drugs
The 2025-2030 World Outlook for MRSA Drugs This study covers the world outlook for MRSA drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2025-2030 World Outlook for Acromegaly
The 2025-2030 World Outlook for Acromegaly This study covers the world outlook for acromegaly across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
Research Assistance
